Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 5/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20458095 | 0.91 | BLM (0.37) | HSD17B10BLMPMP22MEN1POLB | |
| SCHEMBL9359934 | 0.90 | BLM (0.42) | HSD17B10BLMPMP22MEN1POLB | |
| SCHEMBL61362 | 0.90 | BLM (0.42) | HSD17B10BLMPMP22MEN1POLB | |
| SCHEMBL10498370 | 0.90 | BLM (0.42) | HSD17B10BLMPMP22MEN1POLB | |
| SCHEMBL9481973 | 0.90 | BLM (0.42) | HSD17B10BLMPMP22MEN1POLB | |
| SCHEMBL24177721 | 0.90 | BLM (0.42) | HSD17B10BLMPMP22MEN1POLB | |
| SCHEMBL8953515 | 0.90 | BLM (0.42) | HSD17B10BLMPMP22MEN1POLB | |
| SCHEMBL9360302 | 0.90 | HSD17B10 (0.42) | HSD17B10BLMPMP22MEN1POLB | |
| SCHEMBL26242025 | 0.90 | HSD17B10 (0.42) | HSD17B10BLMPMP22MEN1POLB | |
| SCHEMBL9356208 | 0.90 | HSD17B10 (0.42) | HSD17B10BLMPMP22MEN1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180044280-A1 | Y-TYPE DISCRETE POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREOF | JENKEM TECHNOLOGY CO., LTD. (BEIJING) (CN) | 2018-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180044280-A1 | Y-TYPE DISCRETE POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREOF | IDUA, YWHAZ, DDOST | HSD17B10 2701/4885BLM 810/4885PMP22 336/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.